Former co-founder and CEO of 54gene, Abasi Ene-Obong, announced on Monday the establishment of Syndicate Bio, a new genomics company.
Ene-Obong revealed that Syndicate Bio has emerged from stealth mode with a primary focus on advancing global genomics inclusivity. He emphasized the company’s commitment to spearheading genomics and precision medicine initiatives across the world’s most diverse regions, beginning with Africa.
Syndicate Bio has appointed Jumi Popoola as Chief Scientific Officer and Estelle Dogbo as Chief Operating Officer. Additionally, Wubrest T. Bekele, Wissam Hamou, and Aminu Yakubu will assume leadership roles within the company.
Ene-Obong expressed enthusiasm about forthcoming updates on the significant progress made in pursuit of the company’s vision and mission.
